 intraderm hepat vaccin avail vaccin immun hepat viru hbv minim impact diseas mass immun intraderm vaccin preced prophylaxi infecti diseas low-cost altern tradit intramuscular hbv vaccin result open compar trial similar seroconvers rate intraderm intramuscular hbv vaccin rout healthi adult antibodi titer durat antibodi protect intraderm hbv vaccin data suggest demograph factor age gender vaccin respons hbv vaccin advers skin reaction common deterr intraderm hbv vaccin need large-scal prospect compar trial valu intraderm hbv vaccin nevertheless potenti econom epidemiolog benefit intraderm vaccin justifi investig prevent hbv infect